RxDoctor Payments Data

Brittany Turbeville

Family · Greensboro, NCNPI 1891041778

Payments from drug & device makers

$3,854in general payments, 2019–2025

Across 233 payments — averaging $16.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$836
  • Novo Nordisk$699
  • AbbVie$257
  • Abbott$216
  • Boehringer Ingelheim$157
  • Sanofi-aventis U.S. LLC$137
  • plus $2K from 30 others

What the payments were for

  • Food & beverage$3,76998%
  • Education$852%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,854 in reported general payments places this provider in the 90th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin15$14,516
OzempicSemaglutide11$8,890
Cefdinir44$702
Olmesartan Medoxomil38$459
Irbesartan26$367
Escitalopram Oxalate30$355
Metformin Hcl ErMetformin Hcl14$335
Prednisone75$261
Donepezil Hcl16$228
Amlodipine Besylate40$218
Rosuvastatin Calcium17$216
Omeprazole19$212
Ondansetron OdtOndansetron13$207
Losartan Potassium14$188
Tizanidine Hcl17$181

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$157$14,51615 claims
Novo NordiskOzempic$699$8,89011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,522 family providers in North Carolina.

Other family in Greensboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →